Joseph Thomas Gutbrod

Mr. Joseph Thomas Gutbrod

Washington University School of Medicine, St. Louis, Missouri, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HBHayden P. Baker
Hayden P. Baker
JGJoseph Thomas Gutbrod
Joseph Thomas Gutbrod
JSJason Strelzow
Jason Strelzow
NMNicholas H. Maassen
Nicholas H. Maassen
LHLewis L He
Lewis L He
Proximal humerus fractures are the third most common fracture type in adults, with their incidence increasing over time. There are varied approaches to both the classification and treatment of proximal humerus fractures. Optimal treatments for this fracture type are still widely open to debate. This review summarizes the current and historical treatment modalities for proximal humerus fractures. In this paper, we provide updates on the advances and trends in the epidemiology, classification, and operative and nonoperative treatments of proximal humerus fractures.

1 June 2023 in Orthopedic Research and Reviews
Verified
Journal Article
Open access
PDF file
HBHayden P. Baker
Hayden P. Baker
JGJoseph Thomas Gutbrod
Joseph Thomas Gutbrod
MCMichael Cahill
Michael Cahill
LSLewis Shi
Lewis Shi
Proximal humeral fractures (PHFs) are a common type of fracture, particularly in older adults, accounting for approximately 5– 6% of all fractures. This article provides a comprehensive review of PHFs, focusing on epidemiology, injury mechanism, clinical and radiographic assessment, classification systems, and treatment options. The incidence of PHFs varies across regions, with rates ranging from 45.7 to 60.1 per 100,000 person-years. Females are more susceptible to PHFs than males, and the incidence is highest in women over the age of 85. The injury mechanism of PHFs is typically bimodal, with high-energy injuries predominant in younger individuals and low-energy injuries in the elderly. Clinical assessment of PHFs involves obtaining a thorough history, physical examination, and evaluation of associated injuries, particularly neurovascular injuries. Radiographic imaging helps assess fracture displacement and plan for treatment. The Neer classification system is the most commonly used classification for PHFs, although other systems, such as AO/OTA, Codman-Hertel, and Resch classifications, also exist. The choice of treatment depends on factors such as patient age, activity level, fracture pattern, and surgeon expertise. Nonoperative management is typically preferred for elderly patients with minimal displacement, while operative fixation is considered for more complex fractures. Nonoperative treatment involves sling immobilization followed by physiotherapy, with good outcomes reported for certain fracture patterns. Operative management options include closed reduction and percutaneous pinning (CRPP), open reduction and internal fixation (ORIF), or arthroplasty. CRPP is suitable for specific fracture patterns, but the quality of reduction is crucial for favorable outcomes. ORIF is used when CRPP is not feasible, and various surgical approaches are available, each with its advantages and potential complications. PHFs are a significant clinical challenge due to their prevalence and complexity. Treatment decisions should be patient centered based on patient factors and fracture severity.

27 September 2024 in Injury
Verified
Journal Article
Open access
JGJoseph Thomas Gutbrod
Joseph Thomas Gutbrod
DSDustin Stwalley
Dustin Stwalley
AMAnna N Miller
Anna N Miller
The literature lacks a large-scale study investigating the effect of surgical fixation timing on early mortality and morbidity outcomes in distal femur fractures. The aims of this study were to determine the effect of fixation timing on in-hospital mortality and morbidity outcomes for operatively treated distal femur fractures retrospectively using large database data. This study is a retrospective analysis using data from the National Trauma Data Bank. Patients were stratified into a fragility cohort (age ≥ 60, ISS < 16) and polytrauma cohort (age < 60, ISS ≥16), with both cohorts analyzed separately. Within each cohort, patients were split into three fixation timing groups: within 24 h, between 24 and 48 h, and greater than 48 h from presentation to the hospital. Fixation-timing groups were compared based on the primary outcome of in-hospital mortality rate. Secondary outcomes included hospital length of stay (LOS), ICU length of stay (ICU LOS), days on a ventilator, and complications. The fragility and polytrauma cohorts included 22,045 and 5,905 patients, respectively. The in-hospital mortality rate was 1.23 % in the fragility cohort and 2.56 % in the polytrauma cohort. Multivariate analysis of the fragility cohort showed that fixation greater than 48 h from time of presentation was associated with increased mortality compared to fixation within 24 h (OR 1.89, CI: 1.26-2.83, p=0.002) and between 24 and 48 h (OR 1.63, CI: 1.23-2.15, p<0.001). In the polytrauma cohort, multivariate analysis showed no significant mortality differences between fixation timing groups. Multivariate analysis of morbidity outcomes in both cohorts showed that fixation greater than 48 h was associated with increased LOS, ICU LOS, ventilator days, and complications compared to fixation within 24 h. In the polytrauma cohort, fixation between 24 and 48 h was associated with decreased LOS, ICU LOS, and complications compared to the other two timing groups. Fixation of distal femur fractures before 48 h from presentation may lead to improved mortality and morbidity in older, lower injury severity patients. No significant mortality benefit was observed in younger, polytrauma fractures. Further prospective work is needed to validate these findings.

22 November 2022 in American Journal of Nephrology
Verified
Journal Article
Closed access
PDF file
JGJoseph Thomas Gutbrod
Joseph Thomas Gutbrod
CMCharles Clayton Keys McKay
Charles Clayton Keys McKay
LCLillian Coe
Lillian Coe
KBKristin Bergsland
Kristin Bergsland
FCFredric Coe
Fredric Coe
MMMegan L Prochaska, MD, MPH
Megan L Prochaska, MD, MPH
Introduction: Lowering kidney stone risk and urine calcium oxalate supersaturation is a primary clinical focus for kidney stone prevention and can be achieved with multiple strategies. Common strategies include advice to increase fluid intake, restrict dietary sodium, or prescribing a thiazide-type diuretic. We investigated how physicians make these decisions in real-world practice and evaluate their efficacy based on 24-h urine collections. Methods: We reviewed medical charts for 203 kidney stone formers with idiopathic calcium stones from University of Chicago Kidney Stone Clinic between 2005 and 2020. Patients had three 24-h urines before an initial pre-treatment clinic visit and one follow-up 24-h urine. We analyzed changes in urine composition based on treatment advice using t tests and ANOVA. Results: Patients who received advice to increase fluid intake had lower urine volume at baseline (1.5 vs. 2.5 L/day, p < 0.001) and larger increase in urine volume at follow-up (0.6 vs. 0.1 L/day, p < 0.001) compared to those who did not receive the advice. Patients who were advised to restrict dietary sodium had a higher urine sodium at baseline (208 vs. 139 mEq/day, p < 0.001), a larger reduction in urine sodium (−28 vs. 13 mEq/day, p = 0.002), and larger reduction in urine calcium (−74 vs. −28 mg/day, p = 0.005) compared with those not advised to restrict dietary sodium. Patients started on a thiazide had a higher baseline urine calcium (281 vs. 213 mg/day) and larger reduction in urine calcium (−83 vs. −9 mg/day, p < 0.001) compared with patients not started on a thiazide. In combination, thiazide prescriptions with dietary sodium restriction reduced urine calcium by 99 mg/day and reduced calcium oxalate supersaturation from 8.0 to 5.5 and calcium phosphate supersaturation from 1.4 to 1.0. Conclusion: Providers use 24-h urine data to guide treatment strategy decisions. These strategies achieved the intended effects on urine composition and lowered kidney stone risk.

28 August 2025 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
JGJoseph Thomas Gutbrod
Joseph Thomas Gutbrod
ZHZachery Hong
Zachery Hong
CHChristopher G. Herbosa
Christopher G. Herbosa
DSDustin Stwalley
Dustin Stwalley
JWJenna-Leigh Wilson
Jenna-Leigh Wilson
AMAnna N. Miller
Anna N. Miller
Introduction: Treatment approaches and functional outcomes have been shown to be influenced by a patient's socioeconomic status in certain orthopaedic pathologies. In patients with proximal humerus fractures (PHFs), this study aimed to evaluate the relationship between social deprivation and (1) treatment strategy—including the choice between surgical and nonsurgical management, as well as the type of surgical intervention—and (2) patient-reported outcomes. Methods: We retrospectively reviewed 275 displaced PHFs from a level 1 trauma center. Using the Area Deprivation Index (ADI), patients were assigned social deprivation scores ranging from 0 to 100, with higher scores representing greater deprivation. The Patient-Reported Outcomes Measurement Information System (PROMIS) was used to measure the domains of Physical Function, Upper Extremity, Pain Interference, Depression, and Anxiety. PROMIS scores were grouped into 6-week, 3-month, 6-month, and 1-year follow-up groups, with scores analyzed separately at each time point. The associations between ADI and treatment strategy and PROMIS outcomes were determined using multivariable logistic regression and multivariable linear regression, respectively. Results: ADI showed no significant association with surgical versus nonsurgical treatment (odds ratio = 0.998 [95% confidence interval, 0.987 to 1.010], P = 0.790) or type of surgical treatment (odds ratio = 1.009 [confidence interval, 0.994 to 1.024], reverse total shoulder arthroplasty vs locking compression plate, P = 0.251). In the 6-week, 3-month, 6-month, and 1-year follow-up analyses, ADI showed no significant associations with PROMIS Physical Function, Upper Extremity, Pain Interference, Depression, or Anxiety. Conclusion: This study showed that social deprivation was not markedly associated with treatment strategy or patient-reported outcomes in patients with PHFs. Additional prospective research is needed to clarify the impact of social deprivation on patients with PHFs and to determine the appropriate role of area-based deprivation indices in orthopaedic care.